Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.
今天上午美國股票期貨走高，道瓊斯指數期貨週一上漲超過200點。
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) fell sharply in today's pre-market trading after the company issued an update on the Phase 3 RAISE Trial and reported preliminary first quarter 2024 financial results.
Marinus Pharmicals, Inc.（納斯達克股票代碼：MRNS）的股價在今天的盤前交易中大幅下跌，此前該公司發佈了第三階段RAISE試驗的最新情況，並公佈了2024年第一季度的初步財務業績。
Marinus Pharma reported Prelim ZTALMY (Ganaxolone) net product revenue of $7.4 million to $7.6 million for the first quarter.
Marinus Pharma報告稱，第一季度Prelim ZTALMY（Ganaxolone）的淨產品收入爲740萬至760萬美元。
Marinus Pharmaceuticals shares dipped 74.2% to $1.94in pre-market trading.
Marinus Pharmicals的股價在盤前交易中下跌了74.2％，至1.94美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是一些在今天的盤前交易時段中錄得虧損的大型股票。
- Neumora Therapeutics, Inc. (NASDAQ:NMRA) shares declined 17.1% to $11.25 pre-market trading after the FDA placed a clinical hold on the company's Phase 1 NMRA-266 study.
- Roadzen, Inc. (NASDAQ:RDZN) shares fell 14% to $5.04 in pre-market trading.
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares fell 11.4% to $41.64 in pre-market trading after the company disclosed interim Phase 1/2 data in patients with angelman syndrome after treatment with GTX-102.
- Cogent Biosciences, Inc. (NASDAQ:COGT) shares declined 7.7% to $6.01 in pre-market trading. Cogent Biosciences recently reported preclinical data from CNS-Penetrant ErbB2 Inhibitor Program.
- Polestar Automotive Holding UK PLC (NASDAQ:PSNY) shares fell 7.2% to $1.35 in pre-market trading.
- Molina Healthcare, Inc. (NYSE:MOH) shares fell 7.1% to $350.00 in pre-market trading.
- TORM plc (NASDAQ:TRMD) shares slipped 3.1% to $32.92 in pre-market trading.
- Neumora Therapeutics, Inc.（納斯達克股票代碼：NMRA）股價在盤前交易中下跌17.1％，至11.25美元，此前美國食品藥品管理局對該公司的1期 NMRA-266 研究進行了臨床擱置。
- 路森公司（納斯達克股票代碼：RDZN）股價在盤前交易中下跌14％，至5.04美元。
- Ultragenyx Pharmaceutical Inc.（納斯達克股票代碼：RARE）股價在盤前交易中下跌11.4％，至41.64美元，此前該公司披露了 GTX-102 治療後的天使綜合徵患者的1/2期中期數據。
- Cogent Biosciences, Inc.（納斯達克股票代碼：COGT）股價在盤前交易中下跌7.7％，至6.01美元。Cogent Biosciences最近報告了來自CNS滲透劑eRbB2抑制劑計劃的臨床前數據。
- 英國極星汽車控股有限公司（納斯達克股票代碼：PSNY）股價在盤前交易中下跌7.2％，至1.35美元。
- 莫利納醫療保健公司（紐約證券交易所代碼：MOH）股價在盤前交易中下跌7.1％，至350.00美元。
- TORM plc（納斯達克股票代碼：TRMD）股價在盤前交易中下跌3.1％，至32.92美元。
Now Read This: Top 3 Tech Stocks That May Explode This Month
現在讀這個： 本月可能爆發的三大科技股
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道